Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Commentary
Emerging Classic

Vulnerability of the medical product supply chain: the wake-up call of COVID-19.

Miller FA, Young SB, Dobrow M, et al. Vulnerability of the medical product supply chain: the wake-up call of COVID-19. BMJ Qual Saf. 2020;30(4):331-335. doi:10.1136/bmjqs-2020-012133.

Save
Print
November 25, 2020
Miller FA, Young SB, Dobrow M, et al. BMJ Qual Saf. 2020;30(4):331-335.
View more articles from the same authors.

The COVID-19 pandemic has raised concerns about medical product shortages and demand surges, and the resulting effects on patient safety. This viewpoint discusses medical product supply chain vulnerabilities heightened by the COVID-19 pandemic. The authors summarize the evidence on supply chain resilience and medical product shortage, provide examples to illustrate key vulnerabilities, and discuss reactive and proactive solutions for medical product shortage.

Save
Print
Cite
Citation

Miller FA, Young SB, Dobrow M, et al. Vulnerability of the medical product supply chain: the wake-up call of COVID-19. BMJ Qual Saf. 2020;30(4):331-335. doi:10.1136/bmjqs-2020-012133.